Chromosome transplantation as a novel approach for correcting complex genomic disorders.
Paulis M
Oncotarget. 6(34):35218-30. doi: 10.18632/oncotarget.6143
Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu+ breast cancer without increasing its metastatic potential.
Lizier M
Oncotarget. 7(38):60793-60806. doi: 10.18632/oncotarget.11508
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Meneghini V
Stem Cells Transl Med. 2016 Sep 16;6(2):352-368. doi: 10.5966/sctm.2015-0414
Correction of a Recessive Genetic Defect by CRISPR-Cas9-Mediated Endogenous Repair.
Susani L
CRISPR J. 1:230-238. doi: 10.1089/crispr.2018.0004
Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS
Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
Castelli A
Stem Cells. 2019 Apr 2;37(7):876-887. doi: 10.1002/stem.3006
The role of inflammation in lymphoma.
Carbone A
Adv Exp Med Biol. 816:315-33. doi: 10.1007/978-3-0348-0837-8_12
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells.
Carlo-Stella C
Adv Exp Med Biol. 610:100-11. doi: 10.1007/978-0-387-73898-7_8
Microenvironment-related biomarkers and novel targets in classical Hodgkin’s lymphoma.
Carlo-Stella C, Santoro A
Biomark Med. 2015 Jul 30;9(8):807-17. doi: 10.2217/BMM.15.30
Primary refractory and early-relapsed Hodgkin’s lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.
Carbone A
J Pathol. 2015 Jun 3;237(1):4-13. doi: 10.1002/path.4558